Governmental Partners

• Ministry of Health (MoH), Jordan – Collaboration on disease surveillance, biomarker validation, and clinical trials for early diagnostic platforms.
• Jordan Food and Drug Administration (JFDA) – Regulatory guidance for biosensor development and translational research toward market approval.
• Ministry of Higher Education and Scientific Research (MoHESR) – Funding and support for interdisciplinary research projects and student training programs.
• Jordan University Hospital – Clinical collaboration for testing biosensors in real-world patient samples (blood, saliva, urine, sweat).

Private and Industry Partners

• Jordanian pharmaceutical companies (e.g., Hikma Pharmaceuticals) – Partnership in diagnostic drug development, biosensor-drug hybrid systems, and co-development of point-of-care devices.
• Medical device manufacturers and biotech startups – Joint development and commercialization of nano-biosensor platforms.
• Diagnostic laboratories (e.g., Arab Medical Labs, Biolab) – Field testing, validation, and performance evaluation of biosensor prototypes.

Nongovernmental and Jordanian Organizations

• Health-focused NGOs (e.g., Jordanian Red Crescent Society) – Deployment of affordable, rapid diagnostics for underserved populations.                                                                       
  

International Partners

• International universities and biomedical research centers – Co-development of hybrid nanomaterials for diagnostics, training exchanges, and joint publications.
• World Health Organization (WHO) & Global Health Initiatives – Guidance on global health priorities and biosensor applications in infectious disease detection.